Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMG Managers Montag & Caldwell Growth Fund Class R (MCRGX)

19.65
Net Asset Value
+0.15%
1 Day
+14.85%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
1.37%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation and, secondly, current income. The fund invests primarily in common stocks, convertible preferred stocks, and convertible bonds. The subadviser uses a bottom-up approach to stock selection and seeks high quality, well-established, large-cap companies that the subadviser believes are growing their near-term earnings at an above average rate. The managers define a large-cap company as one having a market capitalization of $5 billion or more at the time of acquisition. It may invest in foreign securities (directly and through depositary receipts).

Performance

1 month+2.24% 3 years+6.83%
3 months+7.44% 5 years+10.59%
1 year+9.87% Since inception+7.38%
Data through --

Peer Comparisonvs. Large growth

 MCRGXCategory
Performance 5-yr return+10.59%+13.87%
Expense ratio1.37%1.14%
Risk 5 year sharpe ratio1.071.23
Net assets$953.8M$3.1B
Average market cap$100.8B$108.1B
Average P/E28.327.0
Portfolio turnover64%64%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAMG Funds
Fund manager & tenureRonald Canakaris / 22 Years
Minimal initial investment$2,000.00
Minimum IRA investment--

Holdings

U.S. stock97.13%
Cash2.87%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 20.99%
Energy 16.69%
Consumer service 11.42%
Healthcare 11.31%
Telecommunication 9.37%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth4.70%
MSFT Microsoft4.60%
FB Facebook4.57%
AAPL Apple4.49%
PCLN Priceline4.30%
GOOGL Google4.27%
V Visa4.02%
TMO Thermo Fisher Scientific Inc3.73%
EW Edwards Lifesciences Corp3.59%
KHC Kraft Heinz Co3.54%